CervoMed Inc (NASDAQ: CRVO) is 357.69% higher on its value in year-to-date trading and has touched a low of $1.80 and a high of $25.92 in the current 52-week trading range. The question becomes, what are the chances the stock will continue to grow shareholders’ wealth in the market. Here’s what analysts think will happen to its price in the coming time. The CRVO stock was last observed hovering at around $14.29 in the last trading session, with the day’s loss setting it -3.58%.
Currently trading at $10.71, the stock is 100.40% and 208.82% above its SMA20 and SMA50 respectively. However, with a daily trading volume of 3.13 million and changing -25.05% at the moment leaves the stock 0.73% off its SMA200. CRVO registered -58.70% loss for a year compared to 6-month loss of -38.69%. The firm has a 50-day simple moving average (SMA 50) of $3.4682 and a 200-day simple moving average (SMA200) of $10.63225.
The stock witnessed a 369.74% gain in the last 1 month and extending the period to 3 months gives it a 435.50%, and is 18.34% up over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 30.32% over the week and 25.57% over the month.
CervoMed Inc (CRVO) has around 15 employees, a market worth around $93.20M and $9.74M in sales. Profit margin for the company is -167.29%. Distance from 52-week low is 495.00% and -58.68% from its 52-week high. The company has generated returns on investments over the last 12 months (-41.56%).
with sales reaching $1.96M over the same period.The EPS is expected to grow by 6.08% this year, but quarterly earnings will post -42.36% year-over-year. Quarterly sales are estimated to shrink -16.41% in year-over-year returns.
CervoMed Inc (CRVO) Top Institutional Holders
69.0 institutions hold shares in CervoMed Inc (CRVO), with institutional investors hold 25.84% of the company’s shares. The shares outstanding are 8.70M, and float is at 5.64M with Short Float at 16.04%. Institutions hold 17.22% of the Float.
The top institutional shareholder in the company is RA CAPITAL MANAGEMENT, L.P. with over 0.82 million shares valued at $13.99 million. The investor’s holdings represent 9.3892% of the CRVO Shares outstanding. As of 2024-06-30, the second largest holder is ARMISTICE CAPITAL, LLC with 0.64 million shares valued at $$10.96 million to account for 7.354 of the shares outstanding. The other top investors are AWM INVESTMENT COMPANY, INC. which holds 0.31 million shares representing 3.6085% and valued at over $5.38 million, while IKARIAN CAPITAL, LLC holds 2.7272 of the shares totaling 0.24 million with a market value of $4.06 million.
CervoMed Inc (CRVO) Insider Activity
The most recent transaction is an insider purchase by ELDER WILLIAM ROBERT,the company’sCFO & GC. SEC filings show that ELDER WILLIAM ROBERT bought 1,000 shares of the company’s common stock on Aug 27 ’24 at a price of $18.16 per share for a total of $18160.0. Following the purchase, the insider now owns 1267.0 shares.
